Abbvie Stock News

NEW YORK, Dec. 13, 2021 /PRNewswire/ -- The female infertility drugs market is expected to be dominated by North America, with the region accounting for 35% of the market''s growth during the forecast period. The US and Canada are the key countries for the female infertility drugs market…

Bank Hapoalim BM raised its stake in AbbVie Inc. (NYSE:ABBV) by 2.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 29,975 shares of the company’s stock after acquiring an additional 780 shares during the period. Bank Hapoalim BM’s holdings in AbbVie were worth […]

B&D White Capital Company LLC grew its position in shares of AbbVie Inc. (NYSE:ABBV) by 284.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 49,230 shares of the companys stock after acquiring an additional 36,430 shares during the quarter. AbbVie accounts for approximately []

New Potomac Partners LLC boosted its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 1.1% in the third quarter, according to its most recent filing with the SEC. The firm owned 23,865 shares of the company’s stock after acquiring an additional 265 shares during the period. AbbVie accounts for 1.8% of New Potomac Partners LLC’s […]

Financial Counselors Inc. raised its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 2.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 468,538 shares of the company’s stock after acquiring an additional 12,785 shares during the quarter. AbbVie makes up about […]

MIAMI, Dec. 13, 2021 /PRNewswire/ -- Brand Institute is proud to announce its successful partnership with Allergan, Inc., an AbbVie company, in naming VUITY, the first and only treatment approved by the U.S. Food & Drug Administration (FDA) to treat age-related blurry near vision

Latest published market study on Global Bio-Pharma Market provides an overview of the current market dynamics in the Bio-Pharma space, as well as what our survey respondentsall outsourcing decision-makerspredict the market will look like in 2027. The study breaks market

Washington Trust Bank lessened its stake in shares of AbbVie Inc. (NYSE:ABBV) by 9.2% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 28,051 shares of the company’s stock after selling 2,840 shares during the period. Washington Trust Bank’s holdings in AbbVie were worth $3,026,000 at the end of the most recent reporting […]

Harel Insurance Investments & Financial Services Ltd. decreased its position in AbbVie Inc. (NYSE:ABBV) by 77.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,200 shares of the companys stock after selling 4,124 shares during the quarter. Harel []

New Jersey, United States,- Verified Market Research has recently published a research report titled, Rheumatoid Arthritis Therapeutics Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. Primary and secondary research methodologies have been used to

Investors hope the combination of laggards will make one go-getter Related Stocks: ABBV , AMGN , BIIB , NSE:BIOCON , MRK , NVS , PFE , RHHBY , VTRS , SNY ,

Community Trust & Investment Co. grew its stake in AbbVie Inc. (NYSE:ABBV) by 227.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,602 shares of the companys stock after purchasing an additional 17,784 shares during the period. Community Trust & []

Shares of AbbVie Inc. (NYSE:ABBV) have been assigned an average recommendation of Buy from the fifteen ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 12-month price objective among brokers that []

Sage Capital Advisors llc boosted its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 1.1% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 40,938 shares of the companys stock after buying an additional 461 shares during the period. AbbVie makes up approximately 1.9% of Sage Capital Advisors llcs investment portfolio, making the []

West Family Investments Inc. boosted its stake in AbbVie Inc. (NYSE:ABBV) by 7.3% in the 3rd quarter, Holdings Channel reports. The firm owned 5,712 shares of the companys stock after buying an additional 387 shares during the quarter. West Family Investments Inc.s holdings in AbbVie were worth $616,000 as of its most recent SEC filing. []